Archived News

A $575,000 National Cancer Institute grant will allow the center’s Arizona Clinical Trials Network to expand partnerships with medical facilities statewide to allow more patients to get access to cancer prevention screenings and cutting-edge treatments.

The CTSA grant, the largest infrastructure and training award from the NIH, supports the translation of research discoveries into improved patient care.

Athletes show us that everyone is susceptible to Valley fever, caused by a fungus that lurks in the dirt of the U.S. Southwest. But they also show us that knowledge is power, and that early diagnosis can make a difference.

Citing 11 cases where their partnership advanced health care, training and learning, the University of Arizona and Banner Health are turning innovation into impact to improve lives across Arizona and beyond from precision medicine to immunotherapy to faster Valley fever diagnoses.

Researchers, including Aaron Scott, MD, associate professor of medicine, modified the chemotherapy drug paclitaxel to more effectively target breast and pancreatic cancer tumors.

The career of physician-scientist Sairam Parthasarathy, MD, tracks with the evolution of sleep science.

A new study led by Dr. Stefano Guerra, professor of medicine, will investigate whether levels of the lung protein CC16 in childhood can predict risk of early chronic obstructive pulmonary disease later in life.

WellDOM, a U of A Department of Medicine initiative led by the vice chair Serena Scott, MD, MBA, that began this spring with a faculty survey, prompted new departmental faculty awards and recently sparked a chess club, has led to a broader Wellness Council college- and Banner-wide to refocus on interprofessional wellbeing programs and events.

The award funds a sabbatical for Stefano Guerra, MD, PhD, MPH, to better understand biomarkers that may dictate a child’s developing chronic obstructive pulmonary disease late in life.

A study published in the journal Obesity led by researchers at the U of A Cancer Center emphasizes the need for improved and standardized methods to measure body fat. The work is the first systematic review to focus on advanced body composition techniques — beyond traditional metrics like body mass index — and their associations with colorectal cancer incidence.